Skip to content
Governance Register

← US public companies

Senti Biosciences, Inc.\

SEC CIK 1854270 · SNTI · last insider filing 2026-03-11

Directors (from insider filings)

NameCapacity as filedFilings
Lu Timothy K Director · CEO and President filed 2022 - 2026
Baum Bryan Daniel Director filed 2025 - 2025
Mathers Edward T Director filed 2022 - 2025
Collins James J. Director filed 2022 - 2025
Tang Donald F Director filed 2024 - 2025
Cooperstone Brenda Director filed 2022 - 2025
Schulz Fran Director filed 2024 - 2025
Hsiung Feng Director filed 2025 - 2025
Farokhzad Omid Director filed 2021 - 2024
Berland Susan D Director filed 2022 - 2023
Epstein David R Director filed 2021 - 2022
Dynamics Sponsor LLC Director filed 2021 - 2022
Flatley JAY T Director filed 2021 - 2021
Ronaghi Mostafa Director · Chief Executive Officer filed 2021 - 2021
Nishar Dipchand Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Rajangam Kanya Pres. & Chief Med. & Dev. Off. filed 2022 - 2026
Cross John Harry III Chief Financial Officer filed 2025 - 2025
Li Yvonne Interim CFO filed 2024 - 2024
Knobelman Deborah Chief Financial Officer filed 2022 - 2024
Lee Philip J Chief Technology Officer filed 2022 - 2023
Herberts Curt A. III Chief Operating Officer filed 2022 - 2022
Chapman Rowan E Chief Business Officer filed 2021 - 2021
Afrasiabi Mark Chief Financial Officer filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.